University of California San Francisco

Give to UCSF
Advanced
959 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

The Coming Dearth of Doctors who Specialize in HIV/AIDS

<p>As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.</p>

Placeholder image

Program Empowers the Community Through University Partnership

<p>Projects involving UCSF and community partners that encourage children to learn about medical careers, maintain proper dental hygiene and lose weight by learning to swim were recently celebrated for improving the health and well-being of San Franciscans.</p>

Placeholder image

AIDS: The Struggle Continues

<p>Ellen Schell, RN, PhD, director of International Programs for the Global AIDS Interfaith Alliance and an associate adjunct professor in the UCSF School of Nursing, reflects on the uphill battle to combat AIDS in Malawi, a tiny, impoverished country of 15 million.</p>

Placeholder image

AIDS Prevention 2.0: A Historic Opportunity to Halt HIV

<p>As we mark World AIDS Day this week, the U.S. Centers for Disease Control (CDC) and Prevention reports that more than a million Americans now live with the disease, and every year some 50,000 people in the United States alone are newly infected.</p>

30 Years of AIDS

<p>UCSF has been working for the past 30 years as a leader in AIDS basic and clinical research, patient care, policy development and community and global outreach – efforts that continue today.</p>

Placeholder image

First Bay Area Science Festival Draws Thousands

<p>More than 21,000 people converged to AT&T Park for the first annual Bay Area Science Festival, a spectacularly successful community outreach event sponsored in part by UCSF.</p>

Placeholder image

Low Level HIV in Bloodstream Not Linked With Inflammation or Death

Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.

Placeholder image